Publication | Closed Access

Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway

InflammationMolecular PharmacologyCardiomyopathyMolecular PhysiologyCardiovascular DiseaseIsoprenaline-induced Cardiac HypertrophyPhysiologyPharmacologyCardiovascular PharmacologyPten/akt/mtor PathwayPharmacotherapyMedicineCardiologyOxidative Stress